Skip to main content
Clinical Trials/NCT01319708
NCT01319708CompletedPhase 1

Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation

National and Kapodistrian University of Athens1 site in 1 country50 target enrollmentStarted: March 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
number of oocytes (COCs)

Study Overview

Brief Summary

The investigators will examine the balance between IVF success in terms of outcome parameters, using a mild ovarian stimulation protocol, opposing it to the conventional stimulation regimens in poor responders undergoing IVF.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
25 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • poor responders (age>40, previous POR, abnormal OR test)
  • indication for IVF
  • regular cycling patients
  • BMI 19-35

Exclusion Criteria

  • contraindication for clomiphene citrate use or to GnRH agonists antagonists
  • BMI > 35

Arms & Interventions

mild ovarian stimulation

Experimental

100 mg CC by day 2 till 6, plus antagonist plus gonadotrophin 150-200IO until HCG triggering

Intervention: mild ovarian stimulation (Procedure)

conventional ovarian stimulation

Active Comparator

300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses using a GnRH agonist long protocol

Intervention: conventional ovarian stimulation (Procedure)

Outcomes

Primary Outcomes

number of oocytes (COCs)

Time Frame: at oocyte recovery

Secondary Outcomes

  • Number/rate of participants whom the IVF cycle was cancelled(After the 1st week of ovarian stimulation, no oocytes at OR)
  • clinical pregnancy rate(6 weeks)
  • cancellation rate(from start of stimulation until ET)
  • live birth(more than 20 weeks)
  • miscarriage(pregnancy loss before 20 weeks of gestation, after a positive pregnancy test)
  • stimulation characteristics(from start of stimulation until embryo transfer)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Siristatidis Charalampos, MD, PhD

Assistant Professor, Director of the ARU

National and Kapodistrian University of Athens

Study Sites (1)

Loading locations...

Similar Trials